Collectively, our findings suggest that MBD2 deficiency mitigates SLE development by inhibiting the GC reaction and humoral immunity-related cell differentiation, thereby reducing autoimmune reactions and subsequent renal injury. This evidence concerns the gene MBD2 and systemic lupus erythematosus.